62 filings
8-K
SILO
SILO Pharma Inc
5 Apr 24
Other Events
4:01pm
8-K
SILO
SILO Pharma Inc
1 Feb 24
Silo Pharma Announces Pipeline Prioritization for 2024 Targeting Mental Health, Chronic Pain, and Neurology
1:15pm
8-K/A
SILO
SILO Pharma Inc
11 Jan 24
Other Events
12:15pm
8-K
SILO
SILO Pharma Inc
9 Jan 24
Other Events
4:30pm
8-K
SILO
SILO Pharma Inc
11 Dec 23
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
wvcca
5 Dec 23
Amendments to Articles of Incorporation or Bylaws
4:05pm
8-K
h5mqqg79mms6
4 Dec 23
Submission of Matters to a Vote of Security Holders
4:55pm
8-K
3zkotmyrvp3c12o
14 Nov 23
Entry into a Material Definitive Agreement
4:15pm
8-K
b8xmsz9z2onjg
31 Aug 23
Other Events
7:30am
8-K
6le s3p0r46zyz3da
29 Jun 23
Other Events
4:31pm
8-K
2mvbg71
27 Mar 23
Silo Pharma Announces filing of Patent for Treatment of Fibromyalgia
9:05am
8-K
rljklj kjnfi
15 Feb 23
Silo Pharma Announces Filing of Patent for Treatment of Alzheimer’s
4:15pm
8-K
l7mi5njfnfub ld4
3 Feb 23
Silo Pharma Announces Expansion of Intellectual Property Portfolio
8:00am
8-K
sulh1germ06d v55lbqw
31 Jan 23
Silo Pharma Announces Stock Repurchase Program
4:15pm
8-K
93x7a56g2n
20 Jan 23
Other Events
8:00am
8-K
pvou87e1
1 Dec 22
Silo Pharma Issues Letter to Shareholders Detailing Progress on Pipeline Assets Combining Traditional Therapeutics with Psychedelic Medicine
4:16pm
8-K
9rfgtnpvl eb
18 Oct 22
Entry into a Material Definitive Agreement
5:15pm
8-K
1df7o466 7qed
30 Sep 22
Silo Pharma Announces Uplisting to Nasdaq Capital Market and Pricing of $5 Million Public Offering of Common Stock
8:45am
8-K
t8g0ivxq ua8
15 Sep 22
Silo Pharma Announces Implementation of 1-for-50 Reverse Stock Split in Preparation for Planned Uplisting to Nasdaq
5:24pm
8-K
jjgui6 voj
11 Mar 22
Submission of Matters to a Vote of Security Holders
4:03pm